Aortyx: Funding, Investors & Team (Sep 2026)
Aortyx is an innovative company created by scientists from IQS School of Engineering and Hospital Clínic de Barcelona with the goal of developing advanced endovascular devices for treating vascular diseases. Our technology is designed to promote tissue regeneration by replicating the biomechanical properties of the aorta, creating an environment that supports cell movement and growth on a bioresorbable platform that closely resembles the natural dynamics of the aorta.
Aortyx has raised $18.4M across 2 funding rounds on record, the most recent a Series A of $16.0M announced in Jun 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aortyx Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Aortyx Funding Rounds
Aortyx raised $2.4M in an undisclosed round announced in Apr 2021.
4.2 years later, a Series A of $16.0M was announced in Jun 2025.
Aortyx Founders and Leadership Team
Contact details for the Aortyx team: 1 of 1 has an email address on file.
Start 14-day free trial →Aortyx Funding Compared to Other Biotechnology Startups
Aortyx's latest round of $16.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aortyx in Biotechnology and Barcelona
Companies Similar to Aortyx
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
Aortyx Funding FAQs
What does Aortyx do?
Aortyx is an innovative company created by scientists from IQS School of Engineering and Hospital Clínic de Barcelona with the goal of developing advanced endovascular devices for treating vascular diseases. Our technology is designed to promote tissue regeneration by replicating the biomechanical properties of the aorta, creating an environment that supports cell movement and growth on a bioresorbable platform that closely resembles the natural dynamics of the aorta.
How much funding has Aortyx raised?
Aortyx has raised $18.4M across 2 rounds on record. The most recent is a Series A of $16.0M announced in Jun 2025.
When did Aortyx last raise funding?
Aortyx's most recent funding round on record is a Series A of $16.0M, announced in Jun 2025.
Who founded Aortyx?
FundedIQ lists Jordi Martorell (Founder) at Aortyx.
Where is Aortyx headquartered?
Aortyx is based in Barcelona, Catalonia, Spain.
How many employees does Aortyx have?
Aortyx is in the 11-50 employee band.
How does Aortyx's funding compare to other Biotechnology startups?
Aortyx's latest round of $16.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Aortyx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aortyx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.